Keyphrases
Interleukin-2
100%
Interferon-α (IFN-α)
100%
5-fluorouracil (5-FU)
100%
Phase I Study
100%
Metastatic Renal Cell Carcinoma (mRCC)
100%
Natural Killer Cell Activity
33%
Lymphokine-activated Killers
22%
Antitumor Activity
11%
Complete Response
11%
Hypotension
11%
Primary Tumor
11%
% Response
11%
Intensive Care Unit
11%
2-dose
11%
Hematotoxicity
11%
Mucositis
11%
Platelets
11%
Liver Damage
11%
Maximum Tolerated Dose
11%
Dose-limiting Toxicity
11%
Biologic Activity
11%
Granulocytes
11%
Dose Level
11%
Three-drug Regimen
11%
Unit Support
11%
Interleukin-5 (IL-5)
11%
Lymphokine-activated Killer Cells
11%
Objective Response
11%
Treatment-related Mortality
11%
Simultaneous Delivery
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Interleukin 2
100%
Fluorouracil
100%
Interferon
100%
Lymphokine
33%
Hypotension
11%
Liver Injury
11%
Biological Product
11%
Mucosa Inflammation
11%
Combination Drug
11%
Gamma Interferon
11%
Primary Tumor
11%
Maximum Tolerated Dose
11%
Interleukin 5
11%
Immunology and Microbiology
Interleukin 2
100%
interferon
100%
Cancer Cell
100%
Natural Killer Cell
33%
Lymphokine
22%
Platelet
11%
Cell Activation
11%
Biological Product
11%
Granulocyte
11%
Interferon Gamma
11%
Lymphokine Activated Killer Cell
11%
Interleukin 5
11%
Maximum Tolerated Dose
11%